Become a serial acquirer
Build and run a super-compounding, serial acquisition holding company with Compounding Labs behind you.
A dual engine of growth: Organic and Compounding
Our compounding machine: Organic growth generates cash, reinvested in multiple acquisitions for exponential growth over time.
Our secret sauce
The CL approach to company building is radically different. Our iconoclastic model, the product of many years’ experience, compounds not only capital but values like loyalty, integrity and trust. Result: exponential growth.
Serial acquisition focus
Compounding Labs backs talented, wildly ambitious “serial acquirers” to invest in recurring revenue businesses in niche B2B markets, compounding growth through multiple acquisitions over the long- term. Our CEO’s are fueled to do something special on their own terms.
Identifying the winners
The distinctive, deeply researched CP sourcing system identifies businesses with recurring or predictable revenue, low churn (great customer relationships), long-term secular growth tailwinds, significant cash flow generation, strength in niche markets, and potential for opportunistic consolidation. Growth is both organic and “inorganic” (via acquisition).
IMPROVABILITY
Value-based strategy increases free cash flow and productivity on high-potential acquisitions
DECENTRALIZATION
Our companies have full autonomy & local decision-making. You run it, with CL as responsive partner
EQUITY EFFICIENCY
Call it the equity “paleo diet.” We prioritize value-growth with no incremental equity to get to “Triple-E”
LONG TERMISIM
Our preferred holding period is long-term, offering profound advantages to owners and employees
The Flywheel Effect
The Compounding Labs model is a force multiplier. High returns on capital plus continuous reinvestment plus compounding create a flywheel effect: more cash → more acquisitions → more cash, with the bold ambition (often met) of triple-digit MOIC (Multiple On Invested Capital).
Our co-founders are also our lead investors
Compounding Labs’ iconoclastic approach to business building is the product of many years’ lived experience of the co-founders, who were early pioneers in the search fund space, and who now invest their own capital in the CL portfolio of long-term serial acquisition holding companies.
Nonstop learning
Compounding Labs CEOs are voracious learners. Our research team feeds this passion with CL publications, and a Substack that taps into wisdom of greats like Warren Buffett and Charlie Munger. Plus, you share insights with CL CEO peers.